Stock Research: Alkem Laboratories

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Alkem Laboratories

BSE:539523 INE540L01014
52
  • Value
    46
  • Growth
    51
  • Safety
    Safety
    55
  • Combined
    52
  • Sentiment
    60
  • 360° View
    360° View
    52
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Alkem Laboratories Ltd. is an India-based pharmaceutical company focused on developing, manufacturing, and selling pharmaceutical products. The company operates in pharmaceuticals, producing branded generics, generic drugs, active pharmaceutical ingredients (APIs), and nutraceuticals, with offerings in various medical fields including anti-infectives, cardiology, oncology, and more. It markets products in India and over 40 international markets, with the United States as a key focus. In the last fiscal year, the company had a market cap of $6958 millions, profits of $960 millions, and revenue of $1517 millions.

more
Index
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
46 61 51 71
Growth
51 25 97 37
Safety
Safety
55 46 42 57
Sentiment
60 27 80 26
360° View
360° View
52 22 88 47
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
34 15 25 62
Opinions Change
55 31 50 13
Pro Holdings
n/a 42 83 20
Market Pulse
87 54 83 67
Sentiment
60 27 80 26
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
46 61 51 71
Growth
51 25 97 37
Safety Safety
55 46 42 57
Combined
52 28 85 61
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
43 58 38 64
Price vs. Earnings (P/E)
49 48 50 59
Price vs. Book (P/B)
45 45 44 54
Dividend Yield
60 56 47 62
Value
46 61 51 71
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
58 48 44 39
Profit Growth
56 47 86 34
Capital Growth
6 16 79 73
Stock Returns
75 35 91 47
Growth
51 25 97 37
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
54 44 48 44
Refinancing
61 60 62 64
Liquidity
52 47 37 57
Safety Safety
55 46 42 57

Similar Stocks

Discover high‑ranked alternatives to Alkem Laboratories and broaden your portfolio horizons.

Cipla

NSEI:CIPLA
Country: India
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

Fleury

BOVESPA:FLRY3
Country: Brazil
Industry: Health Care Services
Size: Medium
Full Stock Analysis

Maruti Suzuki

NSEI:MARUTI
Country: India
Industry: Automobile Manufacturers
Size: Large
Full Stock Analysis

Bosch

BSE:500530
Country: India
Industry: Auto Parts & Equipment
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

This stock offers a high growth opportunity with safe financing and positive sentiment. It is typically expensive (low Value Rank), as investors pay a premium for high performance. It is for growth-focused investors comfortable paying a premium for a stock with strong future momentum.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: